About | Kithara

Why Kithara exists

A steadier place to begin.

Kithara exists to support informed, cautious understanding of a high-stakes experimental substance without turning uncertainty into certainty.

We provide clear, evidence-first explanations of ibogaine terminology, research, regulation, and safety considerations. The resource is designed for people who need definitions and context before they evaluate claims, conversations, or decisions. The context behind depression-related claims is one example of why careful language and limits matter.

Our work is organized for practical reading: terms, evidence, safety context, regulatory material, and plain-language explanations sit in distinct places so that readers can identify what a statement means and what it does not establish. That same orientation shapes the resource’s main guide, while our approach to accessible reference material explains how Kithara structures its public information.

Editorial principles

What guides the work.

Kithara is built around independence, safety awareness, plain language, evidence before claims, and respect for uncertainty.

Independence

We are an independent information resource. We do not present clinical marketing as neutral explanation, including material that may accompany an ibogaine retreat in Mexico or a treatment destination.

Evidence before claims

We distinguish between a claim, a preliminary finding, and established evidence. For general research literacy, the National Center for Biotechnology Information provides access to biomedical literature and research records.

III

Plain language, real limits

Definitions should clarify rather than persuade. We use ordinary language while preserving important caveats, especially where a phrase such as treatment for addiction could otherwise imply more certainty than the underlying material supports.

Our standard of care

The source should be visible behind the statement.

Where possible, Kithara checks terminology and factual framing against research registries, published literature, official records, and primary materials. We favor descriptions that make the boundary between evidence and interpretation legible.

That standard means not treating promotional language as proof. It also means acknowledging when information is incomplete, contested, or changing. The public record at ClinicalTrials.gov is one useful starting point for seeing how studies are registered and described.

Our editorial approach

A framework for reading high-stakes information.

We organize material so readers can move from definitions to context without confusing a term with a recommendation. Explanations are checked for scope, source quality, and wording that could overstate confidence.

Use registries, literature, and official sources where they are relevant to a factual statement.
Separate descriptive information from medical, legal, or personal decision-making advice.
Identify uncertainty instead of smoothing it away for a simpler narrative.
Use direct language when safety concerns, gaps, or limits need to be stated.

Independent by design

Information without a clinical claim.

Kithara is for families, researchers, and people evaluating claims who want careful definitions and context. We do not provide diagnosis, treatment, referral, legal interpretation, or individualized guidance. Discussions of purported therapy benefits and listings such as an ibogaine clinic in Tijuana should be read as prompts for further scrutiny, not as endorsements.

For a concise overview of the resource’s terms-and-context orientation, return to the evidence context for depression discussions alongside the site’s broader reference materials. Kithara remains independent of clinics and treatment centers, and it respects the limits of what an information resource can responsibly say.

KitharaIndependent information resource

Review safety and risk context